ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $111,000 | -9.8% | 44,556 | -1.9% | 0.00% | 0.0% |
Q1 2017 | $123,000 | -16.9% | 45,425 | -10.7% | 0.00% | -33.3% |
Q4 2016 | $148,000 | -29.2% | 50,876 | 0.0% | 0.00% | -25.0% |
Q3 2016 | $209,000 | +29.8% | 50,876 | -0.0% | 0.00% | +33.3% |
Q2 2016 | $161,000 | – | 50,888 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |